The effectiveness allows selling shareholders to immediately sell their shares into the market, creating severe dilution pressure. Monitor for any registered sales or further equity issuances. The going concern opinion amplifies downside risk.
Price Chart
Executive Summary
The SEC declared effective Lifeward's Form S-3 registration statement (File 333-295352) filed on April 27, 2026. This shelf registration covers 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds and its auditor has expressed substantial doubt about its ability to continue as a going concern.
Key Facts
- EFFECT notice for Form S-3 (333-295352) effective May 12, 2026
- S-3 registers 7,256,474 ordinary shares for resale by Oramed Pharmaceuticals and Creative Value Capital LP
- Resale shares represent ~261% of current shares outstanding ($18M market cap)
- Lifeward receives no proceeds from the resale offering
- Auditor has raised substantial doubt about going concern
Financial Impact
Potential overhang of 261% of shares outstanding; no proceeds to company
Risk Factors
- Massive dilution from selling shareholder overhang
- Going concern uncertainty
- Further equity issuances possible
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001589 |
| Document: 9999999995-26-001589-index.html | 9999999995-26-001589 |
| Document: 9999999995-26-001589.txt | 9999999995-26-001589 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $7.45 $7.11 | ▼ −4.56% | ▼ −2.57% | $5.85 (−21.48%) |
Aug 14, 2026 7w ago | Press Release | $7.45 $7.11 | ▲ +4.56% | ▲ +2.57% | $5.85 (+21.48%) |
Aug 11, 2026 7w ago | EFFECT | $7.57 $7.40 | ▲ +2.18% | ▲ +1.12% | $5.85 (+22.67%) |
Aug 7, 2026 8w ago | Press Release | $7.69 $6.98 | ▼ −9.17% | ▼ −8.78% | $5.85 (−23.88%) |
May 19, 2026 19w ago | 8-K | $6.40 $6.98 | ▲ +9.06% | ▲ +8.08% | $5.85 (−8.59%) |
May 15, 2026 20w ago | 8-K | $6.70 $6.96 | ▼ −3.81% | ▼ −1.69% | $5.85 (+12.69%) |
May 15, 2026 20w ago | Press Release | $6.70 $6.96 | ▼ −3.81% | ▼ −1.69% | $5.85 (+12.69%) |
May 13, 2026 20w ago | EFFECT | $6.63 $6.80 | ▼ −2.56% | ▼ −3.18% | $5.85 (+11.76%) |
May 11, 2026 20w ago | Press Release | $6.40 $6.98 | ▲ +9.09% | ▲ +9.40% | $5.85 (−8.59%) |
Apr 27, 2026 22w ago | S-3 | $7.09 $6.98 | ▲ +1.55% | ▲ +7.02% | $5.85 (+17.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access